A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer.

Bader A Abdelmaksoud, Abdelmotaleb Mohammed,Mostafa M Toam

Asian Pacific journal of cancer prevention : APJCP（2020）

引用 1|浏览0

暂无评分

摘要

Extended adjuvant treatment for 6 months with metronomic docetaxel after the primary standard of care therapy was tolerated and has an encouraging survival benefit in patients with operable TNBC and these results need further evaluation in randomized control studies.
.

查看译文

关键词

Docetaxel,TNBC,extended adjuvant therapy,metronomic chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要